Phenotypic and Functional Characterization of Long-Term Cryopreserved Human Adipose-derived Stem Cells

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Yong, Kar Wey ^a,b   Pingguan Murphy, Belinda ^a   Xu, Feng ^b   Abas, Wan Abu Bakar Wan ^a   Choi, Jane Ru ^b   Omar, Siti Zawiah ^a   Azmi, Mat Adenan Noor ^a   Chua, Kien Hui ^c   Safwani, Wan Kamarul Zaman Wan ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ADULT STEM CELL; BONE DEVELOPMENT; CELL CULTURE TECHNIQUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF-RENEWAL; CELL SEPARATION; CELL SURVIVAL; CHONDROGENESIS; CRYOPRESERVATION; CYTOLOGY; FEMALE; HUMAN; IMMUNOPHENOTYPING; METABOLISM; PHENOTYPE; TIME FACTOR; YOUNG ADULT;

ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ADULT STEM CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SELF RENEWAL; CELL SEPARATION; CELL SURVIVAL; CHONDROGENESIS; CRYOPRESERVATION; FEMALE; HUMANS; IMMUNOPHENOTYPING; OSTEOGENESIS; PHENOTYPE; TIME FACTORS; YOUNG ADULT;

EID: 84928136633     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09596     Document Type: Article

References (51)

1. Mimeault, M., Hauke, R. & Batra, S. K. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin. Pharmacol. Ther. 82, 252-264 (2007).
2. Arthur, A., Zannettino, A. & Gronthos, S. The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair. J. Cell. Physiol. 218, 237-245 (2009).
3. Doulatov, S. & Daley, G. Q. Development. A stem cell perspective on cellular engineering. Science 342, 700-702 (2013).
4. Rubin, J. P. & Marra, K. G. Adipose stem cell therapy for soft tissue reconstruction. Lancet 382, 1077-1079 (2013).
5. Gomillion, C. T. & Burg, K. J. Stem cells and adipose tissue engineering. Biomaterials 27, 6052-6063 (2006).
6. Mizuno, H., Tobita, M. & Uysal, A. C. Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine. Stem Cells 30, 804-810 (2012).
7. Kolle, S. F. et al. Enrichment of autologous fat grafts with ex-vivo expanded adipose tissue-derived stem cells for graft survival: a randomised placebo-controlled trial. Lancet 382, 1113-1120 (2013).
8. Davies, O. G., Smith, A. J., Cooper, P. R., Shelton, R. M. & Scheven, B. A. The effects of cryopreservation on cells isolated from adipose, bone marrow and dental pulp tissues. Cryobiology 69, 342-347 (2014).
9. Hubel, A. Parameters of cell freezing: implications for the cryopreservation of stem cells. Transfus. Med. Rev. 11, 224-233 (1997).
10. Liu, G. et al. Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose-derived stem cells. Cryobiology 57, 18-24 (2008).
11. Gonda, K. et al. Preserved proliferative capacity and multipotency of human adipose-derived stem cells after long-term cryopreservation. Plast. Reconstr. Surg. 121, 401-410 (2008).
12. Thirumala, S., Gimble, J. M. & Devireddy, R. V. Evaluation ofmethylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells. Stem Cells Dev. 19, 513-522 (2010).
13. De Rosa, A. et al. A newmethod for cryopreserving adipose-derived stem cells: an attractive and suitable large-scale and long-term cell banking technology. Tissue Eng. Part C Methods 15, 659-667 (2009).
14. Thirumala, S., Wu, X., Gimble, J. M. & Devireddy, R. V. Evaluation of polyvinylpyrrolidone as a cryoprotectant for adipose tissue-derived adult stem cells. Tissue Eng. Part C Methods 16, 783-792 (2010).
15. James, A. W. et al. Deleterious effects of freezing on osteogenic differentiation of human adipose-derived stromal cells in vitro and in vivo. Stem Cells Dev. 20, 427-439 (2011).
16. Song, Y. S. et al. Vitrification and levitation of a liquid droplet on liquid nitrogen. Proc. Natl. Acad. Sc.i U. S. A. 107, 4596-4600 (2010).
17. Zhang, X., Catalano, P. N., Gurkan, U. A., Khimji, I. & Demirci, U. Emerging technologies in medical applications of minimum volume vitrification. Nanomedicine (Lond.) 6, 1115-1129 (2011).
18. Tedder, R. S. et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet 346, 137-140 (1995).
19. Guven, S. & Demirci, U. Integrating nanoscale technologies with cryogenics: a step towards improved biopreservation. Nanomedicine (Lond.) 7, 1787-1789 (2012).
20. Gao, D. & Critser, J. K. Mechanisms of cryoinjury in living cells. ILAR J. 41, 187-196 (2000).
21. Li, Y., Tan, J. C. & Li, L. S. Comparison of three methods for cryopreservation of human embryonic stem cells. Fertil. Steril. 93, 999-1005 (2010).
22. Samot, J. et al. Blood banking in living droplets. PLoS One 6, e17530 (2011).
23. Zambelli, A. et al. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res. 18, 4705-4708 (1998).
24. Benekli, M. et al. Severe respiratory depression after dimethylsulphoxide-containing autologous stem cell infusion in a patient with AL amyloidosis. Bone Marrow Transplant 25, 1299-1301 (2000).
25. Windrum, P. & Morris, T. C. Severe neurotoxicity because of dimethyl sulphoxide following peripheral blood stem cell transplantation. Bone Marrow Transplant 31, 315 (2003).
26. Tuschong, L., Soenen, S. L., Blaese, R. M., Candotti, F. & Muul, L. M. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum. Gene Ther. 13, 1605-1610 (2002).
27. Lee, Y. A. et al. Cryopreservation in trehalose preserves functional capacity of murine spermatogonial stem cells. PLoS One 8, e54889 (2013).
28. Katkov, II et al. Cryopreservation by slow cooling with DMSO diminished production of Oct-4 pluripotency marker in human embryonic stem cells. Cryobiology 53, 194-205 (2006).
29. Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317 (2006).
30. Choi, J. R. et al. In Situ Normoxia Enhances Survival and Proliferation Rate of Human Adipose Tissue-Derived Stromal Cells without Increasing the Risk of Tumourigenesis. PLoS One 10, e0115034 (2015).
31. Wan Safwani, W. K., Makpol, S., Sathapan, S. & Chua, K. H. The changes of stemness biomarkers expression in human adipose-derived stem cells during long-term manipulation. Biotechnol. Appl. Biochem. 58, 261-270 (2011).
32. Choi, J. R. et al. Hypoxia Promotes Growth and Viability of Human Adipose-Derived Stem Cells with Increased Growth Factors Secretion. J. Asian Sci. Res. 4, 328-338 (2014).
33. Karlsson, J. O. & Toner, M. Long-term storage of tissues by cryopreservation: critical issues. Biomaterials 17, 243-256 (1996).
34. Xu, F. et al. Multi-scale heat and mass transfer modelling of cell and tissue cryopreservation. Philos. Trans. A Math. Phys. Eng. Sci. 368, 561-583 (2010).
35. Berz, D., McCormack, E. M., Winer, E. S., Colvin, G. A. & Quesenberry, P. J. Cryopreservation of hematopoietic stem cells. Am. J. Hematol. 82, 463-472 (2007).
36. Karlsson, J. O. Cryopreservation: freezing and vitrification. Science 296, 655-656 (2002).
37. Zeisberger, S. M. et al. Biological and physicochemical characterization of a serum- and xeno-free chemically defined cryopreservation procedure for adult human progenitor cells. Cell Transplant 20, 1241-1257 (2011).
38. Li, Y. & Ma, T. Bioprocessing of cryopreservation for large-scale banking of human pluripotent stem cells. Biores. Open Access 1, 205-214 (2012).
39. Muldrew, K. & McGann, L. E. Mechanisms of intracellular ice formation. Biophys. J. 57, 525-532 (1990).
40. Janz Fde, L. et al. Evaluation of distinct freezing methods and cryoprotectants for human amniotic fluid stem cells cryopreservation. J. Biomed. Biotechnol. 2012, 649353 (2012).
41. Choi, J. R. et al. Impact of low oxygen tension on stemness, proliferation and differentiation potential of human adipose-derived stem cells. Biochem. Biophys. Res. Commun. 448, 218-224 (2014).
42. Bosnakovski, D. et al. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol. Bioeng. 93, 1152-1163 (2006).
43. Datta, N. et al. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc. Natl. Acad. Sci. U. S. A. 103, 2488-2493 (2006).
44. Han, S. et al. The three-dimensional collagen scaffold improves the stemness of rat bone marrow mesenchymal stem cells. J. Genet. Genomics 39, 633-641 (2012).
45. Boyer, L. A. et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122, 947-956 (2005).
46. Yoon, D. S., Kim, Y. H., Jung, H. S., Paik, S. & Lee, J. W. Importance of Sox2 in maintenance of cell proliferation and multipotency of mesenchymal stem cells in low-density culture. Cell Prolif. 44, 428-440 (2011).
47. Greco, S. J., Liu, K. & Rameshwar, P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells 25, 3143-3154 (2007).
48. Seo, K. W. et al. OCT4A contributes to the stemness and multi-potency of human umbilical cord blood-derived multipotent stem cells (hUCB-MSCs). Biochem. Biophys. Res. Commun. 384, 120-125 (2009).
49. Fan, Y. X. et al. Oct4 and Sox2 overexpression improves the proliferation and differentiation of bone mesenchymal stem cells in Xiaomeishan porcine. Genet. Mol. Res. 12, 6067-6079 (2013).
50. Liu, T. M. et al. Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells. Stem Cells Dev. 18, 1013-1022 (2009).
51. Pierantozzi, E. et al. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Stem Cells Dev. 20, 915-923 (2011).